Rocky Mountain translational hub to bring discoveries to patients
Official title: Rocky Mountain REACH (RMT-REACH)
Funded at University of Montana · NIH-11415108 · Data updated 2026-11-12
A Montana hub will speed up turning university discoveries into real health tools that help people, especially in remote states.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Montana NIH-funded |
| Lab location | 1 site (Missoula, United States) |
| Project start | September 25, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $948,496 |
| NIH project number | 5U01GM152530-04 |
| Project ID | NIH-11415108 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are patients in Montana and WWAMI region who could benefit from new diagnostics, devices, or therapies that emerge from this translational effort.
✕Less likely to help
Patients whose health needs are outside the focus of technologies developed through this hub may not benefit.
What this research studies
The University of Montana leads a regional program to connect scientists, clinicians, and entrepreneurs so new diagnostics, devices, and therapies can reach patients faster. It partners with multiple institutions across the WWAMI region and WE-REACH for guidance and collaboration. The effort focuses on building sustainable infrastructure and resources to support innovators in resource-limited areas, with the goal of reducing disease burden. This is about turning basic research into practical health solutions that communities can actually use.
Why it matters
Potential benefit: If successful, this hub could accelerate the development and dissemination of new health technologies that benefit people in Montana and nearby states.
How similar studies have gone: Similar regional translational hubs have shown promise in moving academic discoveries toward real-world health solutions, though outcomes vary by implementation.
Where this research is happening
-
University of Montana
Missoula, United States Active
Researchers
- Principal investigator: Woodahl, Erica L — University of Montana
- Study coordinator: Woodahl, Erica L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.